✦ LIBER ✦

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis

✍ Scribed by Ayumi Yoshizaki; Koichi Yanaba; Asako Yoshizaki; Yohei Iwata; Kazuhiro Komura; Fumihide Ogawa; Motoi Takenaka; Kazuhiro Shimizu; Yoshihide Asano; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 506 KB
Volume: 62
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.27498

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The specific free radical scavenger edar

The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis

✍ Ayumi Yoshizaki; Koichi Yanaba; Asako Ogawa; Yohei Iwata; Fumihide Ogawa; Motoi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Treatment with imatinib prevents fibrosi

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

✍ Alfiya Akhmetshina; Paulius Venalis; Clara Dees; Nicole Busch; Jochen Zwerina; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Trichostatin A prevents the accumulation

Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis

✍ Lars C. Huber; Jörg H. W. Distler; Falk Moritz; Hossein Hemmatazad; Thomas Hause 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

## Abstract ## Objective Tissue fibrosis is a hallmark compromising feature of many disorders. In this study, we investigated the antifibrogenic effects of the histone deacetylase inhibitor trichostatin A (TSA) on cytokine‐driven fibrotic responses in vitro and in vivo. ## Methods Skin fibroblas

Monocyte chemoattractant protein 3 as a

Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse

✍ Voon H. Ong; Lowri A. Evans; Xu Shiwen; Ivan B. Fisher; Vineeth Rajkumar; David 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 2 views

α-melanocyte–stimulating hormone suppres

α-melanocyte–stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: Melanocortin peptides as a novel treatment strategy for scleroderma?

✍ Agatha Kokot; Anca Sindrilaru; Meinhard Schiller; Cord Sunderkötter; Claus Kerkh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

## Abstract ## Objective Recently, we found that human dermal fibroblasts (HDFs) express melanocortin 1 receptors (MC‐1R) that bind α‐melanocyte–stimulating hormone (α‐MSH). In search of novel therapies for scleroderma (systemic sclerosis [SSc]), we used the bleomycin (BLM) model to investigate th